Cargando…
Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma
INTRODUCTION: Biomarkers, such as Estrogen Receptor, are used to determine therapy and prognosis in breast carcinoma. Immunostaining assays of biomarker expression have a high rate of inaccuracy; for example, estimates are as high as 20% for Estrogen Receptor. Biomarkers have been shown to be hetero...
Autores principales: | Tolles, Juliana, Bai, Yalai, Baquero, Maria, Harris, Lyndsay N, Rimm, David L, Molinaro, Annette M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218938/ https://www.ncbi.nlm.nih.gov/pubmed/21592345 http://dx.doi.org/10.1186/bcr2882 |
Ejemplares similares
-
Quantitative Assessment Shows Loss of Antigenic Epitopes as a Function of Pre-analytic Variables
por: Bai, Yalai, et al.
Publicado: (2011) -
Quantitative measurements of HER2 and phospho-HER2 expression: correlation with pathologic response to neoadjuvant chemotherapy and trastuzumab
por: Cheng, Huan, et al.
Publicado: (2014) -
Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts
por: Baquero, Maria T, et al.
Publicado: (2011) -
The relationship of p53 immunostaining to survival in carcinoma of the lung.
por: McLaren, R., et al.
Publicado: (1992) -
Optimization of immunostaining on flat-mounted human corneas
por: Forest, Fabien, et al.
Publicado: (2015)